About us

Ola Myklebost leder kreftgenomikk-prosjektet.
Ola Myklebost leder kreftgenomikk-prosjektet.

About us

Norwegian Cancer Genomics Consortium (NCGC) consists of clinicians and specialised cancer research groups, situated at the Norwegian University Hospitals. The participants collaborate on two large research projects, focused on cancer genomics. The projects, which have received 75 M NOK in funding from the Norwegian Research Council, aim to establish new clinical practises for cancer treatment. The projects are led by the associated group leaders, Tom Dønnem (UNN), Bjørn Tore Gjertsen (HUS), Jutta Heix (Oslo Cancer Cluster), Harald Holte (OUS), Eivind Hovig (OUS), Ragnhild Lothe (OUS), Per Eystein Lønning (HUS), Leonardo Meza-Zepeda (OUS), Ola Myklebost (OUS), Sissel Rogne (Bioteknologirådet), Ole Morten Seternes (UiT), Jan Helge Solbakk (UiO, vara Sissel Rogne), Giske Ursin (KR), Anders Waage (St Olav). Eyrun Thune is the coordinator.

Contacts

Ola Myklebost

Professor, Project leader

ola@kreftgenomikk.no

+47 5558 4565

 

 

Liv Cecilie Vestrheim Thomsen

Co-ordinator

liv@kreftgenomikk.no

+47 909 35 449


The Project Leadership

Erlend B Smeland

Professor, Forskningsdriektør OUS, – Styreleder

 

Jónas Einarsson

Direktør Radiumhospitalets forskningsstiftelse

 

Anne Sameline Grimsgaard

Professor, Forskningsdekan UNN/UiT

 

Bjørn Gustafsson

Professor, Forskningsdekan StOlav/NTNU

 

Tove Flem Jacobsen

VP Science & Regulatory at Aker BioMarine Antarctic

 

Edvin W Johannesen

Seniorrådgiver – Forskningsadministrasjon UiO

 

Olav Mella

Professor, Avdelingssjef Haukeland/UiB

 

Knut Martin Torgersen

Medisinsk rådgiver Pfizer

Partners